SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-277196
Filing Date
2023-11-14
Accepted
2023-11-14 17:12:56
Documents
77
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d370982d10q.htm   iXBRL 10-Q 1704793
2 EX-3.1 d370982dex31.htm EX-3.1 61402
3 EX-10.14 d370982dex1014.htm EX-10.14 7418
4 EX-31.1 d370982dex311.htm EX-31.1 10326
5 EX-31.2 d370982dex312.htm EX-31.2 10364
6 EX-32.1 d370982dex321.htm EX-32.1 5512
12 GRAPHIC g370982page1.jpg GRAPHIC 5368
  Complete submission text file 0001193125-23-277196.txt   7176820

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA trml-20230930.xsd EX-101.SCH 48515
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trml-20230930_cal.xml EX-101.CAL 34666
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trml-20230930_def.xml EX-101.DEF 271939
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE trml-20230930_lab.xml EX-101.LAB 426140
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trml-20230930_pre.xml EX-101.PRE 364718
71 EXTRACTED XBRL INSTANCE DOCUMENT d370982d10q_htm.xml XML 1019689
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40384 | Film No.: 231407915
SIC: 2836 Biological Products, (No Diagnostic Substances)